PT  - JOURNAL ARTICLE
AU  - Ardabili, Sina F.
AU  - Mosavi, Amir
AU  - Ghamisi, Pedram
AU  - Ferdinand, Filip
AU  - Varkonyi-Koczy, Annamaria R.
AU  - Reuter, Uwe
AU  - Rabczuk, Timon
AU  - Atkinson, Peter M.
TI  - COVID-19 Outbreak Prediction with Machine Learning
AID  - 10.1101/2020.04.17.20070094
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.17.20070094
4099  - http://medrxiv.org/content/early/2020/04/22/2020.04.17.20070094.short
4100  - http://medrxiv.org/content/early/2020/04/22/2020.04.17.20070094.full
AB  - Several outbreak prediction models for COVID-19 are being used by officials around the world to make informed-decisions and enforce relevant control measures. Among the standard models for COVID-19 global pandemic prediction, simple epidemiological and statistical models have received more attention by authorities, and they are popular in the media. Due to a high level of uncertainty and lack of essential data, standard models have shown low accuracy for long-term prediction. Although the literature includes several attempts to address this issue, the essential generalization and robustness abilities of existing models needs to be improved. This paper presents a comparative analysis of machine learning and soft computing models to predict the COVID-19 outbreak. Among a wide range of machine learning models investigated, two models showed promising results (i.e., multi-layered perceptron, MLP, and adaptive network-based fuzzy inference system, ANFIS). Based on the results reported here, and due to the highly complex nature of the COVID-19 outbreak and variation in its behavior from nation-to-nation, this study suggests machine learning as an effective tool to model the outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is supported within the project of “Support of research and development activities of the J. Selye University in the field of Digital Slovakia and creative industry” of the Research and Innovation Operational Programme (ITMS code:NFP313010T504) co-funded by the European Regional Development Fund.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available on request. https://www.worldometers.info/coronavirus/country